WEKO3
アイテム
An Overview of Innovative Activities in the Chinese Pharmaceutical Industry: Market Trends, Firm Financial Capacity, and Regulatory Environment
https://agi.repo.nii.ac.jp/records/2000082
https://agi.repo.nii.ac.jp/records/2000082eb02b968-dc4d-4e0e-bf55-a66228ec2ad5
| 名前 / ファイル | ライセンス | アクション |
|---|---|---|
report2023-10.pdf (848 KB)
|
.png)
|
| Item type | 調査報告書/Research Reports(1) | |||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 公開日 | 2024-04-10 | |||||||||||
| タイトル | ||||||||||||
| タイトル | An Overview of Innovative Activities in the Chinese Pharmaceutical Industry: Market Trends, Firm Financial Capacity, and Regulatory Environment | |||||||||||
| 言語 | en | |||||||||||
| 言語 | ||||||||||||
| 言語 | eng | |||||||||||
| 資源タイプ | ||||||||||||
| 資源タイプ識別子 | http://purl.org/coar/resource_type/c_18ws | |||||||||||
| 資源タイプ | research report | |||||||||||
| 研究代表者 |
姚, 瑩
× 姚, 瑩
WEKO
334
|
|||||||||||
| 抄録 | ||||||||||||
| 内容記述タイプ | Abstract | |||||||||||
| 内容記述 | This report examines the factors driving drug innovation in the Chinese pharmaceutical industry by analyzing market trends, firm financial capacity, and the regulatory environment spanning from 1990–2022. The descriptive analysis reveals that drugs targeting noncommunicable diseases such as oncology, immunology, and endocrinology have seen a surge in drug development, and that R&D investment decisions of Chinese pharmaceutical companies are influenced more by asset accumulation than by debt and profit margins, in contrast to other contexts. The report also highlights the role of government regulations in incentivizing and shaping pharmaceutical R&D, with regulatory instruments encouraging the development of treatments for rare diseases. However, price pressures linked to government regulations raise concerns about their potential impact on innovation. The findings underscore the challenges in assessing the impact of government regulations on innovative activities and the need for comprehensive data integration across corporate and disease dimensions to better understand the drivers of drug innovation in China’s pharmaceutical industry. | |||||||||||
| 言語 | en | |||||||||||
| 著者版フラグ | ||||||||||||
| 出版タイプ | NA | |||||||||||
| 出版タイプResource | http://purl.org/coar/version/c_be7fb7dd8ff6fe43 | |||||||||||
